BBIO
Closed
Bridgebio Pharma Inc
42.78
-0.40 (-0.93%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 43.18
Day's Range: 41.8 - 43.04
Send
sign up or login to leave a comment!
When Written:
16.58
BridgeBio Pharma Inc. is a biotechnology company that focuses on finding and developing treatments for genetic diseases. The company was founded in 2015 by Neil Kumar and has since grown to include multiple subsidiaries that are each focused on developing therapies for specific genetic diseases. BridgeBio's approach involves identifying and acquiring promising drug candidates from academic institutions and other sources, and then developing them through clinical trials to bring them to market. The company's pipeline includes treatments for a range of genetic diseases, including cancer, skin disorders, and neurological disorders. BridgeBio is headquartered in Palo Alto, California, and is publicly traded on the NASDAQ under the ticker symbol BBIO.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








